Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events

Mohammad Zubaid, Wafa A. Rashed, Alawi A. Alsheikh-Ali, Ibrahim Al-Zakwani, Wael AlMahmeed, Abdullah Shehab, Kadhim Sulaiman, Ahmed Al Qudaimi, Nidal Asaad, Haitham Amin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We describe management and outcomes of patients with nonvalvular atrial fibrillation (AF) in the Middle East. Consecutive patients with AF presenting to emergency departments (EDs) were prospectively enrolled. Among 1721 patients with nonvalvular AF, mean age was 59 ± 16 years and 44% were women. Comorbidities were common such as hypertension (59%), diabetes (33%), and coronary artery disease (33%). Warfarin was not prescribed to 40% of patients with Congestive heart failure, Hypertension, Age, Diabetes mellitus, Stroke/TIA2 score of ≥2. One-year rates of stroke/transient ischemic attack (TIA) and all-cause mortality were 4.2% and 15.3%, respectively. Warfarin use at hospital-ED discharge was independently associated with lower 1-year rate of stroke/TIA (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.17-0.85; P =.015) and all-cause mortality (OR, 0.51; 95% CI, 0.32-0.83; P =.006). Prior history of heart failure and peripheral vascular disease was independent mortality predictors. Our patients are relatively young with significant cardiovascular risk. Their anticoagulation treatment is suboptimal, and 1-year all-cause mortality and stroke/TIA event rates are relatively high.

Original languageEnglish
Pages (from-to)464-471
Number of pages8
JournalAngiology
Volume66
Issue number5
DOIs
Publication statusPublished - May 21 2015

Fingerprint

Middle East
Atrial Fibrillation
Transient Ischemic Attack
Stroke
Mortality
Warfarin
Hospital Emergency Service
Heart Failure
Odds Ratio
Confidence Intervals
Hypertension
Peripheral Vascular Diseases
Hospital Departments
Comorbidity
Coronary Artery Disease
Diabetes Mellitus
Surveys and Questionnaires

Keywords

  • anticoagulation
  • atrial fibrillation
  • Middle East
  • risk assessment
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East : Gulf Survey of Atrial Fibrillation Events. / Zubaid, Mohammad; Rashed, Wafa A.; Alsheikh-Ali, Alawi A.; Al-Zakwani, Ibrahim; AlMahmeed, Wael; Shehab, Abdullah; Sulaiman, Kadhim; Qudaimi, Ahmed Al; Asaad, Nidal; Amin, Haitham.

In: Angiology, Vol. 66, No. 5, 21.05.2015, p. 464-471.

Research output: Contribution to journalArticle

Zubaid, M, Rashed, WA, Alsheikh-Ali, AA, Al-Zakwani, I, AlMahmeed, W, Shehab, A, Sulaiman, K, Qudaimi, AA, Asaad, N & Amin, H 2015, 'Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events', Angiology, vol. 66, no. 5, pp. 464-471. https://doi.org/10.1177/0003319714536980
Zubaid, Mohammad ; Rashed, Wafa A. ; Alsheikh-Ali, Alawi A. ; Al-Zakwani, Ibrahim ; AlMahmeed, Wael ; Shehab, Abdullah ; Sulaiman, Kadhim ; Qudaimi, Ahmed Al ; Asaad, Nidal ; Amin, Haitham. / Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East : Gulf Survey of Atrial Fibrillation Events. In: Angiology. 2015 ; Vol. 66, No. 5. pp. 464-471.
@article{06e0c5c7f0604e10b6d647d4f262dd79,
title = "Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events",
abstract = "We describe management and outcomes of patients with nonvalvular atrial fibrillation (AF) in the Middle East. Consecutive patients with AF presenting to emergency departments (EDs) were prospectively enrolled. Among 1721 patients with nonvalvular AF, mean age was 59 ± 16 years and 44{\%} were women. Comorbidities were common such as hypertension (59{\%}), diabetes (33{\%}), and coronary artery disease (33{\%}). Warfarin was not prescribed to 40{\%} of patients with Congestive heart failure, Hypertension, Age, Diabetes mellitus, Stroke/TIA2 score of ≥2. One-year rates of stroke/transient ischemic attack (TIA) and all-cause mortality were 4.2{\%} and 15.3{\%}, respectively. Warfarin use at hospital-ED discharge was independently associated with lower 1-year rate of stroke/TIA (odds ratio [OR], 0.38; 95{\%} confidence interval [CI], 0.17-0.85; P =.015) and all-cause mortality (OR, 0.51; 95{\%} CI, 0.32-0.83; P =.006). Prior history of heart failure and peripheral vascular disease was independent mortality predictors. Our patients are relatively young with significant cardiovascular risk. Their anticoagulation treatment is suboptimal, and 1-year all-cause mortality and stroke/TIA event rates are relatively high.",
keywords = "anticoagulation, atrial fibrillation, Middle East, risk assessment, stroke",
author = "Mohammad Zubaid and Rashed, {Wafa A.} and Alsheikh-Ali, {Alawi A.} and Ibrahim Al-Zakwani and Wael AlMahmeed and Abdullah Shehab and Kadhim Sulaiman and Qudaimi, {Ahmed Al} and Nidal Asaad and Haitham Amin",
year = "2015",
month = "5",
day = "21",
doi = "10.1177/0003319714536980",
language = "English",
volume = "66",
pages = "464--471",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East

T2 - Gulf Survey of Atrial Fibrillation Events

AU - Zubaid, Mohammad

AU - Rashed, Wafa A.

AU - Alsheikh-Ali, Alawi A.

AU - Al-Zakwani, Ibrahim

AU - AlMahmeed, Wael

AU - Shehab, Abdullah

AU - Sulaiman, Kadhim

AU - Qudaimi, Ahmed Al

AU - Asaad, Nidal

AU - Amin, Haitham

PY - 2015/5/21

Y1 - 2015/5/21

N2 - We describe management and outcomes of patients with nonvalvular atrial fibrillation (AF) in the Middle East. Consecutive patients with AF presenting to emergency departments (EDs) were prospectively enrolled. Among 1721 patients with nonvalvular AF, mean age was 59 ± 16 years and 44% were women. Comorbidities were common such as hypertension (59%), diabetes (33%), and coronary artery disease (33%). Warfarin was not prescribed to 40% of patients with Congestive heart failure, Hypertension, Age, Diabetes mellitus, Stroke/TIA2 score of ≥2. One-year rates of stroke/transient ischemic attack (TIA) and all-cause mortality were 4.2% and 15.3%, respectively. Warfarin use at hospital-ED discharge was independently associated with lower 1-year rate of stroke/TIA (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.17-0.85; P =.015) and all-cause mortality (OR, 0.51; 95% CI, 0.32-0.83; P =.006). Prior history of heart failure and peripheral vascular disease was independent mortality predictors. Our patients are relatively young with significant cardiovascular risk. Their anticoagulation treatment is suboptimal, and 1-year all-cause mortality and stroke/TIA event rates are relatively high.

AB - We describe management and outcomes of patients with nonvalvular atrial fibrillation (AF) in the Middle East. Consecutive patients with AF presenting to emergency departments (EDs) were prospectively enrolled. Among 1721 patients with nonvalvular AF, mean age was 59 ± 16 years and 44% were women. Comorbidities were common such as hypertension (59%), diabetes (33%), and coronary artery disease (33%). Warfarin was not prescribed to 40% of patients with Congestive heart failure, Hypertension, Age, Diabetes mellitus, Stroke/TIA2 score of ≥2. One-year rates of stroke/transient ischemic attack (TIA) and all-cause mortality were 4.2% and 15.3%, respectively. Warfarin use at hospital-ED discharge was independently associated with lower 1-year rate of stroke/TIA (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.17-0.85; P =.015) and all-cause mortality (OR, 0.51; 95% CI, 0.32-0.83; P =.006). Prior history of heart failure and peripheral vascular disease was independent mortality predictors. Our patients are relatively young with significant cardiovascular risk. Their anticoagulation treatment is suboptimal, and 1-year all-cause mortality and stroke/TIA event rates are relatively high.

KW - anticoagulation

KW - atrial fibrillation

KW - Middle East

KW - risk assessment

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84928010789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928010789&partnerID=8YFLogxK

U2 - 10.1177/0003319714536980

DO - 10.1177/0003319714536980

M3 - Article

C2 - 24904179

AN - SCOPUS:84928010789

VL - 66

SP - 464

EP - 471

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 5

ER -